• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

它通过致癌途径诱导肺癌干细胞自我更新,从而发挥癌基因的作用。

functions as an oncogene by inducing self-renewal of lung cancer stem-like cells via oncogenic pathways.

机构信息

Institute of Life Sciences, Chongqing Medical University, Chongqing, China.

Laboratory of Translational Cancer Stem Cell Research, Chongqing Medical University, Chongqing, China.

出版信息

Int J Biol Sci. 2020 Jan 1;16(3):447-459. doi: 10.7150/ijbs.38672. eCollection 2020.

DOI:10.7150/ijbs.38672
PMID:32015681
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6990901/
Abstract

The mortality rate of lung cancer remains the highest amongst all cancers despite of new therapeutic developments. While cancer stem cells (CSCs) may play a pivotal role in cancer, mechanisms underlying CSCs self-renewal and their relevance to cancer progression have not been clearly elucidated due to the lack of reliable and stable CSC cellular models. In the present study, we unveiled the novel oncogene function of cadherin 1 () via bioinformatic analysis in a broad spectrum of human cancers including lung adenocarcinoma (LUAD), adding a new dimension to the widely reported tumor suppressor function of . Experimentally, we show for the first time that promotes the self-renewal of lung CSCs, consistent with its function in embryonic and normal stem cells. Using the LLC-Symmetric Division (LLC-SD) model, we have revealed an intricate cross-talk between the oncogenic pathway and stem cell pathway in which functions as an oncogene by promoting lung CSC renewal via the activation of the Phosphoinositide 3-kinase (PI3K) and inhibition of Mitogen-activated protein kinase (MAPK) pathways, respectively. In summary, this study has provided evidence demonstrating effective utilization of the normal stem cell renewal mechanisms by CSCs to promote oncogenesis and progression.

摘要

尽管有新的治疗方法发展,肺癌的死亡率仍然是所有癌症中最高的。虽然癌症干细胞(CSCs)可能在癌症中发挥关键作用,但由于缺乏可靠和稳定的 CSC 细胞模型,CSCs 自我更新的机制及其与癌症进展的相关性尚未得到明确阐明。在本研究中,我们通过对包括肺腺癌(LUAD)在内的广泛人类癌症的生物信息学分析,揭示了钙黏蛋白 1()的新致癌基因功能,为广泛报道的功能增加了新的维度。在实验上,我们首次表明促进肺 CSCs 的自我更新,这与其在胚胎和正常干细胞中的肿瘤抑制功能一致。使用 LLC-对称分裂(LLC-SD)模型,我们揭示了致癌途径和干细胞途径之间错综复杂的相互作用,其中通过激活磷脂酰肌醇 3-激酶(PI3K)和抑制丝裂原活化蛋白激酶(MAPK)途径分别促进肺 CSC 更新,从而发挥致癌基因的作用。总之,这项研究提供了证据,证明 CSCs 有效地利用正常干细胞更新机制来促进致癌和进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a485/6990901/53ccc5d111c9/ijbsv16p0447g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a485/6990901/a8d93d839993/ijbsv16p0447g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a485/6990901/eea4658bb9b8/ijbsv16p0447g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a485/6990901/8949b01d1be0/ijbsv16p0447g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a485/6990901/a8409c1c2791/ijbsv16p0447g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a485/6990901/53ccc5d111c9/ijbsv16p0447g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a485/6990901/a8d93d839993/ijbsv16p0447g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a485/6990901/eea4658bb9b8/ijbsv16p0447g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a485/6990901/8949b01d1be0/ijbsv16p0447g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a485/6990901/a8409c1c2791/ijbsv16p0447g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a485/6990901/53ccc5d111c9/ijbsv16p0447g005.jpg

相似文献

1
functions as an oncogene by inducing self-renewal of lung cancer stem-like cells via oncogenic pathways.它通过致癌途径诱导肺癌干细胞自我更新,从而发挥癌基因的作用。
Int J Biol Sci. 2020 Jan 1;16(3):447-459. doi: 10.7150/ijbs.38672. eCollection 2020.
2
Characteristics of the PI3K/AKT and MAPK/ERK pathways involved in the maintenance of self-renewal in lung cancer stem-like cells.PI3K/AKT 和 MAPK/ERK 通路在维持肺癌干细胞自我更新中的特征。
Int J Biol Sci. 2021 Mar 15;17(5):1191-1202. doi: 10.7150/ijbs.57871. eCollection 2021.
3
Nr5a2 promotes cancer stem cell properties and tumorigenesis in nonsmall cell lung cancer by regulating Nanog.Nr5a2 通过调节 Nanog 促进非小细胞肺癌的肿瘤干细胞特性和肿瘤发生。
Cancer Med. 2019 Mar;8(3):1232-1245. doi: 10.1002/cam4.1992. Epub 2019 Feb 10.
4
Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.突触结合蛋白 12(SYT12)基因表达促进肺腺癌的细胞增殖和进展,并涉及磷酸肌醇 3-激酶(PI3K)/蛋白激酶 B(AKT)/雷帕霉素靶蛋白(mTOR)通路。
Med Sci Monit. 2020 Feb 28;26:e920351. doi: 10.12659/MSM.920351.
5
Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells.人类非小细胞肺癌表达假定的癌症干细胞标志物,并表现出多能细胞的转录组特征。
BMC Cancer. 2015 Feb 25;15:84. doi: 10.1186/s12885-015-1086-3.
6
Fibulin-3-mediated inhibition of epithelial-to-mesenchymal transition and self-renewal of ALDH+ lung cancer stem cells through IGF1R signaling.纤维连接蛋白-3 通过 IGF1R 信号抑制上皮-间充质转化和 ALDH+肺癌干细胞的自我更新。
Oncogene. 2014 Jul 24;33(30):3908-17. doi: 10.1038/onc.2013.373. Epub 2013 Sep 9.
7
LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.LPCAT1 通过上调 PI3K/AKT/MYC 通路促进肺腺癌脑转移。
J Exp Clin Cancer Res. 2019 Feb 21;38(1):95. doi: 10.1186/s13046-019-1092-4.
8
Zeb1 Regulates the Symmetric Division of Mouse Lewis Lung Carcinoma Stem Cells through Numb mediated by miR-31.Zeb1 通过 miR-31 调控 Numb 介导的小鼠肺Lewis 癌干细胞的对称分裂。
Int J Biol Sci. 2018 Jul 28;14(11):1399-1410. doi: 10.7150/ijbs.27446. eCollection 2018.
9
Autophagy augments the self-renewal of lung cancer stem cells by the degradation of ubiquitinated p53.自噬通过降解泛素化的 p53 增强肺癌干细胞的自我更新。
Cell Death Dis. 2021 Jan 19;12(1):98. doi: 10.1038/s41419-021-03392-6.
10
MicroRNA-31 inhibits lung adenocarcinoma stem-like cells via down-regulation of MET-PI3K-Akt signaling pathway.微小RNA-31通过下调MET-PI3K-Akt信号通路抑制肺腺癌干细胞样细胞。
Anticancer Agents Med Chem. 2016;16(4):501-18. doi: 10.2174/1871520615666150824152353.

引用本文的文献

1
Cadherin family genes in non-small cell lung cancer: implications for diagnosis, prognosis, and targeted therapy.非小细胞肺癌中的钙黏蛋白家族基因:对诊断、预后及靶向治疗的意义
Am J Transl Res. 2025 May 15;17(5):3718-3737. doi: 10.62347/SDZI3679. eCollection 2025.
2
Epigenetic modifications in early stage lung cancer: pathogenesis, biomarkers, and early diagnosis.早期肺癌中的表观遗传修饰:发病机制、生物标志物与早期诊断
MedComm (2020). 2025 Feb 21;6(3):e70080. doi: 10.1002/mco2.70080. eCollection 2025 Mar.
3
Establishment and application of a zebrafish model of Werner syndrome identifies sapanisertib as a potential antiaging drug.

本文引用的文献

1
Nr5a2 promotes cancer stem cell properties and tumorigenesis in nonsmall cell lung cancer by regulating Nanog.Nr5a2 通过调节 Nanog 促进非小细胞肺癌的肿瘤干细胞特性和肿瘤发生。
Cancer Med. 2019 Mar;8(3):1232-1245. doi: 10.1002/cam4.1992. Epub 2019 Feb 10.
2
Zeb1 Regulates the Symmetric Division of Mouse Lewis Lung Carcinoma Stem Cells through Numb mediated by miR-31.Zeb1 通过 miR-31 调控 Numb 介导的小鼠肺Lewis 癌干细胞的对称分裂。
Int J Biol Sci. 2018 Jul 28;14(11):1399-1410. doi: 10.7150/ijbs.27446. eCollection 2018.
3
Soluble E-cadherin promotes tumor angiogenesis and localizes to exosome surface.
一种沃纳综合征斑马鱼模型的建立与应用确定了司帕替尼为一种潜在的抗衰老药物。
Proc Natl Acad Sci U S A. 2025 Feb 4;122(5):e2413719122. doi: 10.1073/pnas.2413719122. Epub 2025 Jan 30.
4
Construction of a pathomics model for predicting mRNAsi in lung adenocarcinoma and exploration of biological mechanism.构建预测肺腺癌中mRNA稳定性指数(mRNAsi)的病理组学模型并探索其生物学机制。
Heliyon. 2024 Aug 29;10(17):e37100. doi: 10.1016/j.heliyon.2024.e37100. eCollection 2024 Sep 15.
5
DataXflow: Synergizing data-driven modeling with best parameter fit and optimal control - An efficient data analysis for cancer research.DataXflow:将数据驱动建模与最佳参数拟合及最优控制相结合——一种用于癌症研究的高效数据分析方法
Comput Struct Biotechnol J. 2024 Apr 8;23:1755-1772. doi: 10.1016/j.csbj.2024.04.010. eCollection 2024 Dec.
6
Fast and flexible profiling of chromatin accessibility and total RNA expression in single nuclei using Microwell-seq3.使用Microwell-seq3对单细胞核中的染色质可及性和总RNA表达进行快速灵活的分析。
Cell Discov. 2024 Mar 26;10(1):33. doi: 10.1038/s41421-023-00642-z.
7
Human Bronchial Epithelial Cell Transcriptome Changes in Response to Serum from Patients with Different Status of Inflammation.人支气管上皮细胞转录组对不同炎症状态患者血清的反应变化。
Lung. 2024 Apr;202(2):157-170. doi: 10.1007/s00408-024-00679-1. Epub 2024 Mar 17.
8
Timed hazard networks: Incorporating temporal difference for oncogenetic analysis.定时风险网络:纳入时变差异进行oncogenetic 分析。
PLoS One. 2023 Mar 16;18(3):e0283004. doi: 10.1371/journal.pone.0283004. eCollection 2023.
9
The Importance of the Immune System and Molecular Cell Signaling Pathways in the Pathogenesis and Progression of Lung Cancer.免疫系统和分子细胞信号通路在肺癌发病机制和进展中的重要性。
Int J Mol Sci. 2023 Jan 12;24(2):1506. doi: 10.3390/ijms24021506.
10
[Association of CDH1, FANCB and APC Gene Polymorphisms 
with Lung Cancer Susceptibility in Chinese Population].[CDH1、FANCB和APC基因多态性与中国人群肺癌易感性的关联]
Zhongguo Fei Ai Za Zhi. 2022 Sep 20;25(9):658-664. doi: 10.3779/j.issn.1009-3419.2022.102.21.
可溶性 E-钙黏蛋白促进肿瘤血管生成,并定位于外泌体表面。
Nat Commun. 2018 Jun 11;9(1):2270. doi: 10.1038/s41467-018-04695-7.
4
Comparison of tumor biology of two distinct cell sub-populations in lung cancer stem cells.肺癌干细胞中两个不同细胞亚群的肿瘤生物学比较。
Oncotarget. 2017 Jun 13;8(57):96852-96864. doi: 10.18632/oncotarget.18451. eCollection 2017 Nov 14.
5
MK2206 enhances the cytocidal effects of bufalin in multiple myeloma by inhibiting the AKT/mTOR pathway.MK2206通过抑制AKT/mTOR信号通路增强了蟾毒灵对多发性骨髓瘤的细胞杀伤作用。
Cell Death Dis. 2017 May 11;8(5):e2776. doi: 10.1038/cddis.2017.188.
6
Cancer Statistics, 2017.《2017 年癌症统计》
CA Cancer J Clin. 2017 Jan;67(1):7-30. doi: 10.3322/caac.21387. Epub 2017 Jan 5.
7
Non-small-cell lung cancer.非小细胞肺癌。
Nat Rev Dis Primers. 2015 May 21;1:15009. doi: 10.1038/nrdp.2015.9.
8
E-Cadherin repression increases amount of cancer stem cells in human A549 lung adenocarcinoma and stimulates tumor growth.E-钙黏蛋白的抑制增加了人A549肺腺癌中癌症干细胞的数量并促进肿瘤生长。
Cell Cycle. 2016;15(8):1084-92. doi: 10.1080/15384101.2016.1156268.
9
Lung cancer stem cells: The root of resistance.肺癌干细胞:耐药的根源。
Cancer Lett. 2016 Mar 28;372(2):147-56. doi: 10.1016/j.canlet.2016.01.012. Epub 2016 Jan 18.
10
Cancer Stem Cell Plasticity Drives Therapeutic Resistance.癌症干细胞可塑性驱动治疗抗性。
Cancers (Basel). 2016 Jan 5;8(1):8. doi: 10.3390/cancers8010008.